This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Constellation-Calpine deal critics seek another deficiency letter from FERC

( May 19, 2025, 22:44 GMT | Official Statement) -- MLex Summary: Policy organizations opposing Constellation Energy's proposed acquisition of rival electricity provider Calpine have asked the US Federal Energy Regulatory Commission to issue another deficiency letter to the companies to seek information that was not demanded in the agency's most recent deficiency notice. Public Citizen, PennFuture, and Clean Air Council — who, using their initials, call themselves the "PPC Protesters" — said that if this data is not provided, their due process rights will be violated. "Applicants’ failure to present a prima facie case deprives PPC Protestors of notice and a meaningful opportunity to be heard," the PPC protesters said. "And an incomplete application prevents the Commission from a proper review." The protesters also said that they "maintain their opposition" to the Constellation-Calpine deal.See attached documents....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login